Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Adocia    ADOC   FR0011184241

ADOCIA (ADOC)

Delayed Quote. Delayed  - 03/24 05:35:21 pm
18.69 EUR   +0.48%
03/02ADOCIA SAS : annual earnings release
01/30DJEUROPEAN MORNIN : Corporate Events
2016 ADOCIA : and Lilly announce successful completion of an insulin pump..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Adocia
Operates as a clinical-stage biotechnology company

Adocia SA operates as a clinical-stage biotechnology company, which engages in the development of medicines from already approved therapeutic agents.

Its product pipeline includes BioChaperone PDGF, which is in Phase III clinical trials for the treatment of diabetic foot ulcer; BioChaperone insulin that is in Phase I/II clinical trials, as well as in pre-clinical staged for the treatment of diabetes; and Driveln, which is in preclinical stage for the treatment of oncology.

The company was founded by Gérard Soula, OLivier Soula, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.


Sales per Businesses
20142015Delta
EUR (in Million)%EUR (in Million)%
Regenerating Medicine0.704100%36.94100% +5146.59%
Sales per Regions
20142015Delta
EUR (in Million)%EUR (in Million)%
France0.704100%36.94100% +5146.59%
Managers
NameAgeSinceTitle
Gérard Soula PhD, MBA692005Chairman, President & Chief Executive Officer
Valérie Danaguezian-2006Chief Financial Officer & Administrative Director
Olivier Soula PhD, MBA482005Director, Deputy General Manager, Director-R&D
Olivier Martinez PhD, MBA47-Director
Laurent Arthaud55-Director
Dominique Takizawa602011Independent Director
Ekaterina Smirnyagina, PhD502013Independent Director
Rémi Soula PhD, MBA-2005Director-Business Development
David Duracher, PhD--Director-Pharmaceutical Development
Géraldine Favre-Soula--Director-Human Resources Development Department
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 6,847,063 5,249,424 76.7% 3,575 0.1% 76.7%
Shareholders
NameEquities%
Gérard Soula PhD, MBA 898,463 13.1%
BPIFrance Investissement SAS 738,639 10.8%
La Société Hospitalière d'Assurances Mutuelles SA 320,000 4.66%
Olivier Soula PhD, MBA 307,490 4.48%
Rémi Soula PhD, MBA 302,490 4.41%
Norges Bank Investment Management 82,675 1.21%
Aviva Investors France SA 78,416 1.14%
ACG Management SAS 67,439 0.98%
CDC Entreprises Valeurs Moyennes SAS 65,732 0.96%
CM-CIC Asset Management SA 50,080 0.73%
Holdings
NameEquities%Valuation
Adocia (ADOC) 4,1850.061%83,025 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
ADOCIA-69.36%138
AMGEN, INC.13.36%122 060
CELGENE CORPORATION6.59%95 986
GILEAD SCIENCES, INC.-5.73%88 240
REGENERON PHARMACEUTIC..1.61%39 568
ACTELION LTD24.44%29 804
VERTEX PHARMACEUTICALS..22.14%22 354
GENMAB A/S19.86%12 410
TESARO INC18.98%8 580
EXELIXIS, INC.40.24%6 082
HUALAN BIOLOGICAL ENGI..--.--%5 042
TONGHUA DONGBAO PHARMA..-2.46%4 421
KITE PHARMA INC71.36%4 213
NEUROCRINE BIOSCIENCES..8.48%3 657
BLUEBIRD BIO INC42.79%3 598
BIOCON LTD20.55%3 495
CLOVIS ONCOLOGY INC58.31%3 138
ULTRAGENYX PHARMACEUTI..0.01%2 934
INTERCEPT PHARMACEUTIC..7.44%2 899
PEPTIDREAM INC-12.99%2 722
BEIJING SL PHARMACEUTI..--.--%2 706
Sector Bio Therapeutic Drugs
Adocia : Connections
Institut Mérieux SA
BPIFrance Investissement SAS
FAB Pharma SAS
Lyon Place Financière & Tertiaire
Platine Pharma Services SAS
Alizé Pharma SAS
iSTAR Medical SA
Elsalys Biotech SAS
Capricorn Venture Partners NV
Lyon Pôle Bourse
Company contact information
115 avenue Lacassagne
FR-69003 Lyon
France

Phone : +33 (0)4 72 610 610
Fax : +33 (0)4 72 36 39 67
Internet : http://www.adocia.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment B
- CAC All Shares / CAC All-Tradable, CAC Mid Small, CAC PME, CAC Small, EnterNext© PEA-PME 150, Next 150, Next Biotech, PEA, PEA-PME, Tech 40
Stock Exchange Codes
- ISIN Code :  FR0011184241
- Bloomberg Code :  ADOC:FP
- Reuters Code :  ADOC.PA
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem